Relation of Progression of Coronary Artery Calcium to Dementia (from the Multi-Ethnic Study of Atherosclerosis).


Journal

The American journal of cardiology
ISSN: 1879-1913
Titre abrégé: Am J Cardiol
Pays: United States
ID NLM: 0207277

Informations de publication

Date de publication:
15 05 2022
Historique:
received: 04 10 2021
revised: 23 01 2022
accepted: 26 01 2022
pubmed: 16 3 2022
medline: 14 4 2022
entrez: 15 3 2022
Statut: ppublish

Résumé

Baseline coronary artery calcification has been shown to be associated with dementia. However, the value of coronary artery calcium (CAC) progression in the prediction of dementia remains unclear. In this study, we examined the association between CAC progression and dementia in the Multi-Ethnic Study of Atherosclerosis. The Multi-Ethnic Study of Atherosclerosis is a prospective study consisting of 6,814 participants 45 to 84 years of age, free of overt cardiovascular disease at baseline. A total of 5,570 subjects had baseline and follow-up CAC scans approximately 2.5 years apart and were included this analysis. A total of 4,173 of these participants completed cognitive testing with the Cognitive Abilities Screening Instrument (CASI) approximately 10 years after the baseline CAC scan. Dementia diagnoses were identified using International Classification of Diseases codes from hospitalizations, death certificates, and medications used to treat dementia. The absolute change between baseline and follow-up CAC was used to assess CAC progression. Cox proportional hazards and multivariable linear regression models were used to examine the association of CAC progression with incident dementia and with CASI score. Over a median follow-up of 13.2 (interquartile range: 11.2 to 15.3) years, 350 participants developed incident dementia. CAC progression showed no association with dementia risk after adjustment for age, gender, race/ethnicity, vascular risk factors, and baseline CAC score. There was no association of CAC progression with CASI score in any adjusted model. In conclusion, progression of CAC over approximately 2.5 years was not associated with increased risk of dementia after adjustment for demographic variables, vascular risk factors, and baseline CAC.

Identifiants

pubmed: 35287946
pii: S0002-9149(22)00115-1
doi: 10.1016/j.amjcard.2022.01.061
pii:
doi:

Substances chimiques

Calcium SY7Q814VUP

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

69-74

Informations de copyright

Copyright © 2022 Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Disclosures The authors have no conflicts of interest to declare.

Auteurs

Gary S Huang (GS)

Division of Cardiology, Department of Medicine, University of Washington, Seattle, Washington. Electronic address: garysh@uw.edu.

Spencer L Hansen (SL)

Department of Biostatistics, University of Washington, Seattle, Washington.

Robyn L McClelland (RL)

Department of Biostatistics, University of Washington, Seattle, Washington.

Annette L Fitzpatrick (AL)

Department of Epidemiology, University of Washington, Seattle, Washington.

W T Longstreth (WT)

Departments of Neurology and Epidemiology, University of Washington, Seattle, Washington.

Matthew Budoff (M)

Department of Medicine, Lundquist Institute at Harbor-UCLA Medical Center, Torrance, California.

Nathan D Wong (ND)

Heart Disease Prevention Program, Division of Cardiology, Department of Medicine, University of California, Irvine, California.

Akira Fujiyoshi (A)

Department of Public Health, Shiga University of Medical Science, Shiga, Japan; Department of Hygiene, School of Medicine, Wakayama Medical University, Wakayama, Japan.

Younghoon Kwon (Y)

Division of Cardiology, Department of Medicine, University of Washington, Seattle, Washington.

Timothy M Hughes (TM)

Departments of Internal Medicine and Epidemiology and Prevention, Wake Forest School of Medicine, Winston-Salem, North Carolina.

Susan R Heckbert (SR)

Cardiovascular Health Research Unit and Department of Epidemiology, University of Washington, Seattle, Washington.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH